Comprehensive evaluation of metagenomic next‐generation sequencing for pathogen identification in patients with suspected infection: Establishment of a standardized validation workflow

Abstract Metagenomic next‐generation sequencing (mNGS) enables unbiased identification of pathogens directly from clinical specimens. Despite its growing application in the diagnosis of infectious diseases, comprehensive validation of mNGS performance remains limited. This study systematically evaluated the analytical and clinical performance of mNGS through a standardized validation workflow, including analytical evaluation using a reference panel of 12 representative pathogens, in silico simulations involving 108 pathogens, evaluation of diagnostic performance in a retrospective cohort of 499 patients, and assessment of clinical impact in a prospective cohort of 142 patients. Our analyses revealed that mNGS achieved 100% qualitative concordance across both intra‐run and inter‐batch testing. The limit of detection (LoD) ranged from 10.0 to 269.1 copies/mL. No cross‐reactivity was observed between closely related species. Moreover, strong linearity supported its robustness and semiquantitative capability. In silico simulations further confirmed its high performance across a broader range of microorganisms. For the culture‐based comparison, mNGS demonstrated a markedly shorter laboratory turnaround time (28.6 h vs. 136.6 h, p < .001) and a higher positive detection rate (82.7% vs. 47.1%, p < .001) than microbial culture. Using composite clinical diagnosis as the reference standard, mNGS exhibited superior detection sensitivity (78.6% vs. 45.2%, p < .001) and overall accuracy (79.8% vs. 53.7%, p < .001) compared to conventional mictobiological testing (CMT). In the prospective cohort, mNGS contributed to antimicrobial treatment decisions in 101 of 120 infected patients. These findings demonstrate that mNGS may serve as a sensitive adjunct to CMT, particularly when interpreted within a standardized quality‐control and clinical adjudication framework.

Authors

Institutions

Publication Details

Journal
Open Research (University of Surrey)
Published
2026-08-26
DOI
https://doi.org/10.1002/viw2.70196
Primary Topic
Bacterial Identification and Susceptibility Testing
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive evaluation of metagenomic next‐generation sequencing for pathogen identification in patients with suspected infection: Establishment of a standardized validation workflow

Yue Yin, Jiatao Lou, Lin Wang, Yang Han et al.
Open Research (University of Surrey)
Bacterial Identification and Susceptibility Testing
article

Comprehensive evaluation of metagenomic next‐generation sequencing for pathogen identification in patients with suspected infection: Establishment of a standardized validation workflow

Yue Yin, Jiatao Lou, Lin Wang, Yang Han, Chunyan He, Yi Fang, Qiaomei Guo, Liwen Zhong, Zhijing Zhao, Huiqin Jiang, Wen Shu, Xueqing Wang
article en

Abstract

Abstract Metagenomic next‐generation sequencing (mNGS) enables unbiased identification of pathogens directly from clinical specimens. Despite its growing application in the diagnosis of infectious diseases, comprehensive validation of mNGS performance remains limited. This study systematically evaluated the analytical and clinical performance of mNGS through a standardized validation workflow, including analytical evaluation using a reference panel of 12 representative pathogens, in silico simulations involving 108 pathogens, evaluation of diagnostic performance in a retrospective cohort of 499 patients, and assessment of clinical impact in a prospective cohort of 142 patients. Our analyses revealed that mNGS achieved 100% qualitative concordance across both intra‐run and inter‐batch testing. The limit of detection (LoD) ranged from 10.0 to 269.1 copies/mL. No cross‐reactivity was observed between closely related species. Moreover, strong linearity supported its robustness and semiquantitative capability. In silico simulations further confirmed its high performance across a broader range of microorganisms. For the culture‐based comparison, mNGS demonstrated a markedly shorter laboratory turnaround time (28.6 h vs. 136.6 h, p < .001) and a higher positive detection rate (82.7% vs. 47.1%, p < .001) than microbial culture. Using composite clinical diagnosis as the reference standard, mNGS exhibited superior detection sensitivity (78.6% vs. 45.2%, p < .001) and overall accuracy (79.8% vs. 53.7%, p < .001) compared to conventional mictobiological testing (CMT). In the prospective cohort, mNGS contributed to antimicrobial treatment decisions in 101 of 120 infected patients. These findings demonstrate that mNGS may serve as a sensitive adjunct to CMT, particularly when interpreted within a standardized quality‐control and clinical adjudication framework.

Open Research (University of Surrey)
Shanghai Jiao Tong University (CN), Shanghai First People's Hospital (CN), Xi'an Jiaotong University (CN)
Shanghai Municipal Health Commission, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Rising-Star Program
Openalex Percentile: Top 14%
Bacterial Identification and Susceptibility Testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.